Article: Danvers, Mass.-Based Abiomed Seeks Wall Street's Heart with New Device.

By Ross Kerber, The Boston Globe Knight Ridder/Tribune Business News

Jun. 21--With a trial of Abiomed Inc.'s artificial heart nearing completion, the company's new chief executive is looking to get Wall Street's blood moving faster.

The Danvers cardiac-devices company is best-known for its AbioCor artificial heart, which is almost through a clinical trial the company needs before it can start selling the device more widely -- it hopes by early next year.

But chief executive Michael R. Minogue has begun outlining new ambitions for the company's less-glamorous products, as well, external cardiac pumps that assist patients with weak hearts, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!